MedPath

The In Vitro Fertilization - Lipiodol Uterine Bathing Effect Study

Phase 3
Conditions
Endometriosis
In Vitro Fertilization Implantation Failure
Registration Number
NCT00894946
Lead Sponsor
University of Auckland, New Zealand
Brief Summary

The hypothesis of this study is that Lipiodol uterine bathing improves the success rate of in vitro fertilization (IVF) for women with endometriosis or recurrent IVF implantation failure.

Detailed Description

Not available

Recruitment & Eligibility

Status
UNKNOWN
Sex
Female
Target Recruitment
350
Inclusion Criteria
  • 12 or more months infertility
  • Age 18 to 39
  • Endometriosis or recurrent IVF implantation failure
  • Patent fallopian tubes
Exclusion Criteria
  • Iodine allergy
  • Blocked fallopian tube or tubes

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Live birth12 months post-randomization
Secondary Outcome Measures
NameTimeMethod
Clinical pregnancy3 months post-randomization
Adverse events3 & 12 months post-randomization

Trial Locations

Locations (1)

University of Auckland

🇳🇿

Auckland, New Zealand

University of Auckland
🇳🇿Auckland, New Zealand
Neil Johnson, MD
Contact
+64 274 360172
n.johnson@auckland.ac.nz
Neil P Johnson, MD
Principal Investigator
Shelley J Reilly, MRANZCOG
Sub Investigator
Cindy M Farquhar, MD
Sub Investigator
Alistair Stewart
Sub Investigator

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.